Filter by year

Filter by topic

Abzena plc 2018 Annual Report

Abzena plc 2018 Annual Report

MHC Associated Peptide Proteomics

Case Study MAPPs for Vaccine Design To identify MHC class I presented antigens derived from influenza strain H1N1, two sets of human epithelial cells are cultured, one is transfected with H1N1 antigen.

World ADC Presentation 2017

Abzena’s presentation at World ADC 2017 given by Campbell Bunce – Senior Vice President Technical Operations.

Composite Proteins™ Fact Sheet

More information on Abzena’s Composite Protein™ technology. Protein Deimmunisation Technical Flyer

Optimisation of Pharmacokinetics Fact Sheet

Information on a our PEGylation technologies, including a TheraPEG case study on the PEGylation of interferon (IFN) a-2b

Composite Human Antibodies™ Fact Sheet

More information on our antibody humanisation and deimmunisation technology, including a case study on the deimmunisation of an anti-CTLA-4 antibody. Download the technical flyer : Composite-Human-Antibodies-Technical-Flyer.pdf

iTope™ and TCED™ Fact Sheet

More information on Abzena’s iTope™ and TCED™ technology including a detailed look at the results.

EpiScreen™ Time Course T Cell Assay Fact Sheet

More information on the EpiScreen™ time course T cell assay and a case study showing the potential immunogenicity of example candidates. Download (pdf)

Interested in our services? Get In Touch